Claims for Patent: 5,405,945

Summary for Patent: 5,405,945

Title:	DNA encoding reproductive hormones and expression using a minigene
Abstract:	Expression constructs for the alpha subunit common to the four human reproductive hormones are disclosed which have enhanced efficiency. These constructs are characterized by the presence of only one intron interrupting the coding sequence for the alpha subunit.
Inventor(s):	Boime; Irving (St. Louis, MO), Matzuk; Martin M. (St. Louis, MO)
Assignee:	Washington University (St. Louis, MO)
Application Number:	07/950,835
Patent Claims:	1. A recombinant DNA molecule capable of, when contained in a recombinant host cell, expressing the gene encoding the human gonadotropin alpha subunit, said DNA molecule comprising a nucleotide sequence encoding said subunit operably linked to control sequences compatible with said host, wherein said nucleotide sequence contains one intron of the genomic nucleotide sequence encoding said alpha gonadotropin but no other introns. 2. Host cells modified to contain the recombinant DNA molecule of claim 1. 3. A method to produce human gonadotropin alpha subunit which comprises culturing the cells of claim 2 under conditions wherein the nucleotide sequence encoding the human gonadotropin alpha subunit is expressed and recovering the human gonadotropin alpha subunit from the cell culture. 4. Recombinant host cells of claim 2 which are further modified to contain a second DNA molecule capable of expressing the nucleotide sequence encoding the beta subunit of a human glycoprotein hormone selected from the group consisting of FSH, LH, TSH and CG. 5. A method to produce a human glycoprotein hormone selected from the group consisting of FSH, LH, TSH and CG which comprises culturing the cells of claim 4 under conditions wherein the nucleotide sequences encoding the human alpha and beta subunits are expressed and recovering the hormone from the cell culture. 6. The DNA molecule of claim 1 which further is capable of expressing a second nucleotide sequence encoding the beta subunit of a human glycoprotein hormone selected from the group consisting of FSH, LH, TSH and CG. 7. Recombinant host cells modified to contain the DNA molecule of claim 6. 8. A method to produce a human glycoprotein hormone selected from the group consisting of FSH, LH, TSH and CG which method comprises culturing the cells of claim 7 under conditions wherein the nucleotide sequences encoding the alpha subunit and beta subunit are expressed and recovering the human glycoprotein hormone from the cell culture.

Details for Patent 5,405,945

Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Merck Sharp & Dohme Corp.	INTRON A	interferon alfa-2b	For Injection	103132	06/04/1986		2012-04-11
Merck Sharp & Dohme Corp.	INTRON A	interferon alfa-2b	For Injection	103132			2012-04-11
Merck Sharp & Dohme Corp.	INTRON A	interferon alfa-2b	Injection	103132			2012-04-11